Good News in War Against COVID-19

Promising Oxford University Vaccine

Source:  Gilead Sciences

Successful Gilead Sciences Treatment

In the war against COVID-19, some

good news.  Gilead Sciences'

remdesivir has shown improvement

in patients taking it to treat the virus.

That, according to Gilead's own

study.  On top of that, testing by the

National Institution of Allergy and

Infectious Disease also gave the

drug "positive data" results in their own

testing.  This news raised hopes on

Wall Street that a treatment/cure is near

and that the economy may be able to

open safely again.  At the start of trading,

the DJIA shot up 400 points and

Gilead shares were up 9.3%.

Promising Vaccine

Meanwhile, researchers at Oxford

University in the UK say they could 

have a COVID-19 vaccine ready for

humans by the 4th quarter of this year.

Their experimental vaccine has

proven effective in protecting

monkeys from the virus.  Monkeys

given the vaccine did not catch the 

virus after heavy exposure to it.

The scientists are hopeful it will

work in humans and started human

trials last week. Globally, 80 vaccines

are now under development.

... ...